Quaterly Results - Emcure Pharmaceuticals Ltd.
Search Company
Registered Address
Registered & Corporate Office : Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi,
Pune, Maharashtra - 411057
Tel: 020-35070033, 35070000
Email : investors@emcure.com
Website : http://www.emcure.com
Key Officials
Name Designation
Mr. Chetan Rajendra Sharma Co. Secretary & Compl. Officer
Mr. Tajuddin Sabir Shaikh Chief Financial Officer
Listings
BSE , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Mar 25 Dec 24 Sep 24
Sales 1,278.19 1,028.81 1,104.63
Other Income 22.40 19.41 54.93
Total Expenses 773.72 729.09 720.37
Operating Profit 504.47 299.72 384.27
Interest 24.07 19.93 31.40
Gross Profit 242.96 123.90 175.69
Provisions Made 0.00 0.00 0.00
Depreciation 56.91 56.65 56.34
Taxation 46.50 17.05 32.44
Net Profit / Loss 139.56 50.20 86.92
Equity Capital 189.48 189.43 189.10
Balance Sheet
Mar 25 Mar 24 Mar 23
Share Capital 189.48 181.15 180.85
Reserve & Surplus 2,834.88 1,753.95 1,661.02
Revaluation Reserve 0.00 0.00 0.00
Networth 3,024.36 1,935.10 1,841.87
Total debt 655.82 1,414.50 1,667.76
Total Liability 3,680.18 3,349.60 3,509.63
Net Block 1,585.18 1,718.24 1,432.71
Capital work in progress 0.00 106.40 253.10
Investment 677.65 684.00 690.02
Net current asset 1,417.35 840.95 1,133.81
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 3,680.18 3,349.60 3,509.63
Income Statement
  Mar25 Mar24 Mar23
Sales 4,381.92 3,497.66 3,107.09
Other Income 118.81 138.26 125.35
Total Expenses 3,735.09 3,055.77 2,668.59
Operating Profit 646.84 441.89 438.49
Interest 112.96 166.09 166.83
Adjusted PBDIT 765.64 580.15 563.84
Depreciation 224.97 204.83 178.52
Adjusted PBT 427.71 209.23 218.48
Taxation 110.58 39.08 52.28
Net Profit / Loss 317.13 160.83 160.06
Key Ratios
  Mar25 Mar24 Mar23
OPM (%) 14.76 12.63 14.11
GPM (%) 9.62 6.77 8.36
NPM (%) 7.23 4.59 5.15
Earning Retention Ratio 100.00 68.12 78.24
Return on networth (%) 10.48 8.31 8.69
EPS (Rs.) 16.74 8.88 8.85
Dividend payout Ratio 0.00 33.73 22.59
Longterm Debt-Equity Ratio 0.13 0.22 0.32
Current Ratio 1.82 1.60 2.02
Fixed Asset Turnover Ratio 1.25 1.02 0.91
Inventory 1.19 1.04 0.88
Interest coverage Ratio 6.78 3.49 3.38
Registrar Details
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel : 022-49186270
Fax : 49186060
Market Performance
Exchange BSE NSE
Last Traded Price (Rs.) 1,280.30 1,279.80
Last Traded Date 03/07/2025 03/07/2025
Last Traded Time - -
Change (%) 0.70% 0.72%
Day's Open (Rs.) 1,284.95 1,272.10
Previous Close (Rs.) 1,271.40 1,270.60
Day's High (Rs.) 1,289.15 1,290.00
Day's Low (Rs.) 1,252.00 1,251.20
Volume (Rs. In Lacs) 101.63 2475.90
Bid Price (Rs.) 0.00 0.00
Bid Quantity
Offer Price (Rs.) 0.00 0.00
Offer Quantity
Exchange Code 544210 EMCUREEQ
Exchange Group B OtherEQ
Board Meetings
Date Purpose
22/05/2025 Audited Results & Final Dividend
06/02/2025 Quarterly Results
07/11/2024 Quarterly Results
Corporate News
Emcure Pharmaceutica - Trading Window-XBRL
Emcure Pharmaceutica - Trading Window
Emcure Pharmaceutica - Updates
Emcure Pharmaceutica - Intimation Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulati
Emcure Pharmaceutica - Action(s) initiated or orders passed
Share Holding Pattern as on 31/03/2025
Major Holder No. of Shares Percentage (%)
Promoters 147,649,282 77.92
Institutional Investors 12,328,644 6.51
Other Investors 19,064,352 10.06
General Public 10,441,069 5.51